Delivery Order SPE2DX22D0010-SPE2D826FBJ51
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,702.74 for OxyContin tablets (20mg) on August 24, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The work will be...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $5,072.23 to AmerisourceBergen Drug Corp on November 9, 2025, for the supply of OxyContin tablets (20mg). This is a firm fixed-price delivery order with an ultimate completion date of November 10, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs and...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 7, 2025, for the supply of OxyContin tablets (20mg) with a ceiling value of $5,702.74. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The award was competitively awarded...
- The Defense Department's Medical Supply Chain awarded a $5,072.23 delivery order to AmerisourceBergen Drug Corp on November 23, 2025, for the supply of OxyContin tablets (20mg). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 24, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 2, 2025, for the supply of OxyContin 20mg tablets under a firm fixed-price contract valued at $5,072.23. This non-set-aside award is scheduled for completion by November 3, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency. AmerisourceBergen, a major pharmaceutical distributor...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of OxyContin tablets 40mg, with a contract ceiling value of $2,508.63 and an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of OxyContin tablets (20mg) with a ceiling value of $3,304.45. This firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain, awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $1,796.20. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, representing a single-transaction purchase of pharmaceutical inventory. The contract was competitively awarded without set-aside designation, leveraging...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of OxyContin 60mg tablets under a firm fixed-price arrangement. This non-competitive, non-set-aside delivery order carries a ceiling value of $1,246.02 and has an ultimate completion date of September 17, 2025, with an award date of September 16, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 20 mg OxyContin tablets with a ceiling value of $5,072.23 under a firm fixed-price contract type. The award was made on November 30, 2025, with an ultimate completion date of December 1, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBJ51Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of OxyContin tablets (60 mg) with a ceiling value of $1,225.56 and an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), this order leverages the company's established pharmaceutical distribution capabilities to meet federal medical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, fulfills this delivery order as part of its comprehensive portfolio of federal medical supply contracts with the Defense Logistics Agency. The company's extensive experience supplying controlled substances, specialty medications, and generic pharmaceuticals to defense and civilian healthcare systems positions it to efficiently deliver this pain management pharmaceutical to support federal medical operations. This delivery order represents a routine procurement under the broader DLA Pharmaceutical Prime Vendor program infrastructure, which is designed to ensure reliable supply chain access to essential medications across the Department of Defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/25/25 |